(Reuters) - By Ben Hirschler
LONDON, July 19 - European regulators said on Thursday that Sanofi-Aventis SA's obesity pill Acomplia should carry stronger warnings to reflect the risk of psychiatric side effects.
Read more at Reuters.com Government Filings News
LONDON, July 19 - European regulators said on Thursday that Sanofi-Aventis SA's obesity pill Acomplia should carry stronger warnings to reflect the risk of psychiatric side effects.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment